Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice
Authors:
- Teruhiko YoshidaTYTeruhiko Yoshida
- Zhi-Hong YangZYZhi-Hong Yang
- Shinji AshidaSAShinji Ashida
- Zu Xi YuZYZu Xi Yu
- Shashi ShrivastavSSShashi Shrivastav
- Krishna Vamsi RojulpoteKRKrishna Vamsi Rojulpote
- Piroz BaharPBPiroz Bahar
- David NguyenDNDavid Nguyen
- Danielle A. SpringerDSDanielle A. Springer
- Jeeva MunasingheJMJeeva Munasinghe
- Matthew F. StarostMSMatthew F. Starost
- Victoria J. HoffmannVHVictoria J. Hoffmann
Open Access
- 11 June 2025
- journal article
- translational science
- Published by Portland Press Ltd. in Clinical Science
- Vol. 139 (11) , 559-575
Abstract
In United States, six million individuals with sub-Saharan ancestry carry two APOL1 high-risk variants, which increase the risk for kidney diseases. Whether APOL1 high-risk variants increase other diseases under dyslipidemia remains unclear and requires further investigation. We characterized a mouse model to investigate the role of APOL1 in dyslipidemia and cardiovascular diseases (CVDs). Transgenic mice carrying APOL1 (G0 and G1 variants) on bacterial artificial chromosomes (BAC/APOL1 mice) were crossed with the apolipoprotein-E knock-out (ApoE-KO) dyslipidemia and atherosclerosis mouse model. The compound transgenic mice were evaluated for the impact of APOL1 on systemic phenotypes. ApoE-KO mice carrying APOL1-G0 and APOL1-G1 did not show differences in the extent of atherosclerotic lesions or aortic calcification, as evaluated by Sudan IV staining and radiographic examination, respectively. However, ~20% of ApoE-KO; BAC/APOL1-G1 mice developed hydrocephalus and required euthanasia. The hydrocephalus was communicating and likely was due to excess cerebrospinal fluid produced by the choroid plexus, where epithelial cells expressed APOL1. Single-nuclear RNA-seq of choroid plexus identified solute transporter up-regulation and mTORC2 pathway activation in APOL1-G1-expressing epithelial cells. Further, in the All of Us cohort, we found higher hydrocephalus prevalence among individuals with the APOL1-G1 variant in both recessive and dominant models, supporting the mouse findings. While APOL1-G1 expression in ApoE-KO mice did not worsen CVD phenotypes, we uncovered hydrocephalus as a novel APOL1 risk allele-mediated phenotype. These findings extend the spectrum of APOL1-associated pathologies.Keywords
All Related Versions
This publication has 74 references indexed in Scilit:
- A double-edged sword: DLG5 in diseasesBiomedicine & Pharmacotherapy, 2023
- The choroid plexus links innate immunity to CSF dysregulation in hydrocephalusCell, 2023
- Navigating the ventricles: Novel insights into the pathogenesis of hydrocephalusEBioMedicine, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- A cellular and spatial map of the choroid plexus across brain ventricles and agesCell, 2021
- Mouse models of atherosclerosis and their suitability for the study of myocardial infarctionBasic Research in Cardiology, 2020
- DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest NeighborsCell Systems, 2019
- Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneHuman Genetics, 2010
- Failure of Epithelial Tube Maintenance Causes Hydrocephalus and Renal Cysts in Dlg5 MiceDevelopmental Cell, 2007
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsCell, 1992